RESEARCHER PROFILE
Salim Yusuf
S
McMaster University
Salim Yusuf works in Acute Myocardial Infarction Research, Blood Pressure and Hypertension Studies, Heart Failure Treatment and Management, Cardiovascular Health and Risk Factors, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Vanderbilt University, Population Health Research Institute, Hamilton Health Sciences.
2,075Publications
290,230Citations
262H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 · 12,018 citationsDabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 · 11,218 citationsRisk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study
2010 · 3,453 citationsCOLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
1994 · 3,322 citationsBeta blockade during and after myocardial infarction: An overview of the randomized trials
1985 · 3,211 citationsEffects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 · 2,999 citationsGlobal Burden of Cardiovascular Diseases
2001 · 2,972 citationsObesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
2005 · 2,903 citationsEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 · 2,809 citationsEffects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 · 2,606 citationsEffects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2002 · 2,578 citationsRivaroxaban with or without Aspirin in Stable Cardiovascular Disease
2017 · 2,436 citationsApixaban in Patients with Atrial Fibrillation
2011 · 2,433 citationsAssociation of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 · 2,411 citationsGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
2016 · 2,284 citationsThe burden of disease in older people and implications for health policy and practice
2014 · 2,268 citationsEffect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 · 2,134 citationsRadial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 · 2,125 citationsEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.
2000 · 2,094 citationsModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
2019 · 2,000 citationsACC/AHA guidelines for coronary artery bypass graft surgery
1999 · 1,995 citationsEffects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
2003 · 1,889 citationsPrognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study
2015 · 1,868 citationsInterpretation of the evidence for the efficacy and safety of statin therapy
2016 · 1,861 citationsEffects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
2003 · 1,688 citations
